Literature DB >> 17393422

Interaction of MUC1 with beta-catenin modulates the Wnt target gene cyclinD1 in H. pylori-induced gastric cancer.

Gopal Udhayakumar1, Venkatraman Jayanthi, Niranjali Devaraj, Halagowder Devaraj.   

Abstract

Beta-catenin can function as an oncogene when it is translocated to the nucleus, binds to T-cell factor (TCF) or lymphoid enhance factor and transactivate its target gene. The mechanism responsible for the activation of Wnt signaling pathway in the Cytotoxin-associated antigen A (CagA) Helicobacter pylori (H. pylori)-infected gastric carcinoma has not been elucidated. We hypothesize that whether interaction of MUC1 with beta-catenin modulates the Wnt signaling and its target gene cyclinD1 in CagA H. pylori-infected gastric carcinoma. The result demonstrate that binding of MUC1 CT with Protein Kinase C delta (PKC delta), tyrosine phosphorylation of MUC1 CT, and CagA are strongly associated with the interaction of MUC1 with beta-catenin in CagA H. pylori-infected gastric carcinoma. A statistically significant difference (chi(2) = 24.49; P < 0.001) was found when the binding of MUC1 CT and beta-catenin was compared to subcellular localization of beta-catenin. We also observed significant statistical correlation (chi(2) = 14.885; P < 0.001) between the cyclinD1 overexpression and the subcellular localization of beta-catenin. The overexpression of cyclinD1 was significantly higher (chi(2) = 13.785; P < 0.002) in advanced gastric carcinoma with CagA H. pylori infection. In addition cyclinD1 overexpression was significantly higher (chi(2) = 37.267; P < 0.001) with the interaction of MUC1 CT with beta-catenin in advanced gastric cancer. These findings indicate that MUC1 CT plays a role in the intracellular signaling through its interaction with beta-catenin and upregulate the Wnt target gene cyclinD1 in CagA H. pylori-infected gastric carcinoma. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17393422     DOI: 10.1002/mc.20311

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  32 in total

1.  Overexpression of MUC1 enhances proangiogenic activity of non-small-cell lung cancer cells through activation of Akt and extracellular signal-regulated kinase pathways.

Authors:  Mengying Yao; Weihong Zhang; Qingxian Zhang; Lihua Xing; Aiguo Xu; Qiuhong Liu; Bing Cui
Journal:  Lung       Date:  2011-10-01       Impact factor: 2.584

Review 2.  Recent insights into cerebral cavernous malformations: a complex jigsaw puzzle under construction.

Authors:  Eva Faurobert; Corinne Albiges-Rizo
Journal:  FEBS J       Date:  2010-01-22       Impact factor: 5.542

3.  Aberrant expression of β-catenin and its association with ΔNp63, Notch-1, and clinicopathological factors in oral squamous cell carcinoma.

Authors:  Gokulan Ravindran; Halagowder Devaraj
Journal:  Clin Oral Investig       Date:  2011-09-01       Impact factor: 3.573

4.  Bone marrow stroma protects myeloma cells from cytotoxic damage via induction of the oncoprotein MUC1.

Authors:  Michal Bar-Natan; Dina Stroopinsky; Katarina Luptakova; Maxwell D Coll; Arie Apel; Hasan Rajabi; Athalia R Pyzer; Kristen Palmer; Michaela R Reagan; Myrna R Nahas; Rebecca Karp Leaf; Salvia Jain; Jon Arnason; Irene M Ghobrial; Kenneth C Anderson; Donald Kufe; Jacalyn Rosenblatt; David Avigan
Journal:  Br J Haematol       Date:  2017-01-20       Impact factor: 6.998

5.  Nuclear translocation of β-catenin correlates with CD44 upregulation in Helicobacter pylori-infected gastric carcinoma.

Authors:  Gopal Udhayakumar; Venkatraman Jayanthi; Niranjali Devaraj; Halagowder Devaraj
Journal:  Mol Cell Biochem       Date:  2011-06-16       Impact factor: 3.396

Review 6.  Role of the Wnt/β-catenin pathway in gastric cancer: An in-depth literature review.

Authors:  Miguel Angel Chiurillo
Journal:  World J Exp Med       Date:  2015-05-20

7.  Association between cyclin D1 polymorphism with CpG island promoter methylation status of tumor suppressor genes in gastric cancer.

Authors:  Tomomitsu Tahara; Tomoyuki Shibata; Masakatsu Nakamura; Hiromi Yamashita; Daisuke Yoshioka; Masaaki Okubo; Joh Yonemura; Yoshiteru Maeda; Naoko Maruyama; Toshiaki Kamano; Yoshio Kamiya; Hiroshi Fujita; Yoshihito Nakagawa; Mitsuo Nagasaka; Masami Iwata; Ichiro Hirata; Tomiyasu Arisawa
Journal:  Dig Dis Sci       Date:  2010-04-16       Impact factor: 3.199

8.  In vitro and in vivo inhibitory effect of the combination of Wenxia Changfu formula [see text] with cisplatin in non-small cell lung cancer.

Authors:  Xu-ming Ji; Bing Ouyang; Heng Liu; Guo-wei Liu; Zhi-chun Wu; Hua-yun Yu; Chun-yan Wang; Zhong-xia Wang; Wen-ping Wang
Journal:  Chin J Integr Med       Date:  2011-12-03       Impact factor: 1.978

Review 9.  Cerebral cavernous malformations: from molecular pathogenesis to genetic counselling and clinical management.

Authors:  Remco A Haasdijk; Caroline Cheng; Anneke J Maat-Kievit; Henricus J Duckers
Journal:  Eur J Hum Genet       Date:  2011-08-10       Impact factor: 4.246

10.  TRAF4 participates in Wnt/β-catenin signaling in breast cancer by upregulating β-catenin and mediating its translocation to the nucleus.

Authors:  Ailian Wang; Jian Wang; Huanyan Ren; Fan Yang; Lili Sun; Kexin Diao; Zhijuan Zhao; Min Song; Zeshi Cui; Enhua Wang; Minjie Wei; Xiaoyi Mi
Journal:  Mol Cell Biochem       Date:  2014-07-03       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.